Medical City Plano Offers Robotic Lung Biopsy

New technology offers more accurate early-stage lung cancer diagnosis.

Advertisement.

As per their press release, Medical City Plano now offers minimally-invasive, robot-assisted lung biopsies designed to increase accuracy for early-stage diagnosis and improve patient outcomes. Lung cancer is the leading cause of cancer-related deaths in the United States and is often diagnosed at a later stage when curative treatments are often limited.

This fiber optic, shape-sensing technology is designed to address a challenging aspect of lung biopsy by increasing physician’s reach, precision and stability to diagnose possible lung cancer, saving patients’ time, money and stress.

Equipped with an ultra-thin, ultra-maneuverable catheter that allows navigation far into the peripheral lung through the patient’s mouth, which can significantly reduce risks of infection, damage to the lung and false negative diagnoses.

“As the only Sarah Cannon Cancer Hospital in Texas, we are proud to provide advanced and innovative solutions that enhance patient diagnosis and accelerate treatment,” says Ben Coogan, CEO of Medical City Plano. “These high standards of care and leading-edge technology are among the many reasons our community trusts Medical City Plano as the destination of choice for oncology excellence.”

Early-stage detection is important to increase the chances of survival.

The American Cancer Society recommends a low-dose CT scan every year for people aged 50-80 who:

Smoke or used to smoke

AND

Smoked 1 pack a day for 20 years or 2 packs a day for 10 years

The Center for Lung Health at Medical City Plano provides screening, diagnosis and treatment for all types of lung cancers. Staffed with a multidisciplinary team including pulmonologists, medical and radiation oncologists, radiologists, and other lung experts, these specialists review each case as a team to create comprehensive, targeted and effective treatment plans for patients. The Center for Lung Health also has a lung nodule-screening program, designed to detect potential lung issues on CT scans performed on hospitalized patients.